SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001193125-16-578753
Filing Date
2016-05-05
Accepted
2016-05-05 08:01:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 FWP d67753dfwp.htm FWP 14020
  Complete submission text file 0001193125-16-578753.txt   15640
Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filed by) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-210689 | Film No.: 161621622
SIC: 2835 In Vitro & In Vivo Diagnostic Substances